CENTURY ALUMINUM COMPANY (CENX)

US1564311082 - Common Stock

18.09  +0.48 (+2.73%)

Fundamental Rating

2

CENX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 155 industry peers in the Metals & Mining industry. CENX may be in some trouble as it scores bad on both profitability and health. CENX is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

CENX had positive earnings in the past year.
In the past year CENX had a positive cash flow from operations.
In the past 5 years CENX always reported negative net income.
Of the past 5 years CENX 4 years had a positive operating cash flow.

1.2 Ratios

CENX's Return On Assets of -2.43% is in line compared to the rest of the industry. CENX outperforms 48.39% of its industry peers.
With a Return On Equity value of -12.68%, CENX is not doing good in the industry: 68.39% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 2.13%, CENX perfoms like the industry average, outperforming 52.90% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CENX is significantly below the industry average of 9.16%.
Industry RankSector Rank
ROA -2.43%
ROE -12.68%
ROIC 2.13%
ROA(3y)-4.64%
ROA(5y)-5.63%
ROE(3y)-18.45%
ROE(5y)-17.98%
ROIC(3y)2.72%
ROIC(5y)N/A

1.3 Margins

CENX has a Operating Margin (1.46%) which is in line with its industry peers.
With a Gross Margin value of 4.21%, CENX is not doing good in the industry: 65.16% of the companies in the same industry are doing better.
Industry RankSector Rank
OM 1.46%
PM (TTM) N/A
GM 4.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CENX is destroying value.
CENX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CENX has been increased compared to 5 years ago.
CENX has a better debt/assets ratio than last year.

2.2 Solvency

CENX has an Altman-Z score of 0.44. This is a bad value and indicates that CENX is not financially healthy and even has some risk of bankruptcy.
CENX has a worse Altman-Z score (0.44) than 76.13% of its industry peers.
CENX has a debt to FCF ratio of 45.21. This is a negative value and a sign of low solvency as CENX would need 45.21 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 45.21, CENX is doing good in the industry, outperforming 60.65% of the companies in the same industry.
A Debt/Equity ratio of 1.21 is on the high side and indicates that CENX has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.21, CENX is doing worse than 89.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF 45.21
Altman-Z 0.44
ROIC/WACC0.26
WACC8.06%

2.3 Liquidity

CENX has a Current Ratio of 1.14. This is a normal value and indicates that CENX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.14, CENX is doing worse than 83.23% of the companies in the same industry.
CENX has a Quick Ratio of 1.14. This is a bad value and indicates that CENX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.43, CENX is not doing good in the industry: 92.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.43

4

3. Growth

3.1 Past

CENX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.17%, which is quite impressive.
The Revenue for CENX has decreased by -21.31% in the past year. This is quite bad
Measured over the past years, CENX shows a small growth in Revenue. The Revenue has been growing by 2.91% on average per year.
EPS 1Y (TTM)29.17%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q225.81%
Revenue 1Y (TTM)-21.31%
Revenue growth 3Y10.83%
Revenue growth 5Y2.91%
Revenue growth Q2Q-3.32%

3.2 Future

CENX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.34% yearly.
CENX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.72% yearly.
EPS Next Y-118.1%
EPS Next 2Y76.33%
EPS Next 3Y40.34%
EPS Next 5YN/A
Revenue Next Year-6.84%
Revenue Next 2Y2.7%
Revenue Next 3Y7.72%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 58.35, CENX can be considered very expensive at the moment.
CENX's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CENX to the average of the S&P500 Index (25.20), we can say CENX is valued expensively.
The Forward Price/Earnings Ratio is negative for CENX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 58.35
Fwd PE N/A

4.2 Price Multiples

CENX's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, CENX is valued a bit cheaper than 63.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 158.2
EV/EBITDA 18.99

4.3 Compensation for Growth

A more expensive valuation may be justified as CENX's earnings are expected to grow with 40.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y76.33%
EPS Next 3Y40.34%

0

5. Dividend

5.1 Amount

CENX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (4/26/2024, 12:45:35 PM)

18.09

+0.48 (+2.73%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.68B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 58.35
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.43%
ROE -12.68%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.46%
PM (TTM) N/A
GM 4.21%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.14
Quick Ratio 0.43
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)29.17%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-118.1%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-21.31%
Revenue growth 3Y10.83%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y